## RPD: Rapid7, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.30 indicates fundamental undervaluation. Quality metrics strong (ROE 37%). Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-4.7% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($14.33)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($3.90M) |
| Sells | 6 ($0.36M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (+7.4%)
- Blackrock Inc.: 10.1% (-1.1%)
- Jana Partners Manage: 9.9% (+13.5%)
- UBS Group AG: 4.9% (-28.9%)
- Penserra Capital Man: 4.1% (-1.8%)

### Key Risks

1. Long-term trend broken: trading 27.1% below SMA200.
2. Falling knife pattern: rapid decline without stabilization, catch risk elevated.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.30 indicates undervaluation relative to growth. Quality metrics strong (ROE 37%). Insider buying signal ($3.9M), management confidence. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $1.0B |
| Beta | 0.84 |
| 52W Range | $13.21 - $41.38 |
| Short Interest | 7.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.30 |
| Forward P/E | 7.8 |
| Current P/E | 7.5 |
| YoY Growth | -2.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.2% to -1.5% (-4.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.5pp (needs >4.0% for momentum thesis). Below SMA200 (0.73x), long-term trend not supportive. RSI neutral at 45. Elevated volume (2.1x 20MA), institutional activity likely. OFD pattern: -DLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.48% (CS: 34) | Neutral |
| RSI_14 | 45.2 | Neutral |
| MACD Histogram | 0.04 | Bullish |
| vs SMA20 | 0.988x | Below |
| vs SMA50 | 0.950x | Below |
| vs SMA200 | 0.729x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $15.49
- **Stop Loss:** $14.33 (7.5% risk)
- **Target:** $17.81 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1034
- **Position Value:** $16,016.66
- **Portfolio %:** 16.02%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-11 (Est: $0.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.46 | $0.57 | +24.9% |
| 2025Q2 | $0.44 | $0.58 | +30.9% |
| 2025Q1 | $0.34 | $0.49 | +42.3% |
| 2024Q4 | $0.50 | $0.48 | -3.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*